India State FDA Files Complaint against DePuy with Mumbai Police
Posted on December 12, 2011 by Rottenstein Law Group
Those paying attention to the DePuy hip replacement recall no doubt have already heard of people in Australia, England, and the United States suing the manufacturer, DePuy Orthopaedics, a Johnson & Johnson subsidiary. DePuy designed and manufactured the ASR XL Acetabular System and ASR Hip Resurfacing System, both metal-on-metal hip replacements that fail at higher-than-normal rates. Indeed, artificial joint registries in England and Australia both began reporting recipients’ problems with the device, reports that helped trigger the recall. Now, it appears Indian authorities are responding to the ASRs’ failure rates.
State Food and Drug Administration Asks Recipients to Step Forward
Mumbai—formerly called Bombay—is an Indian commercial metropolis located on the county’s west coast in the state of Maharashtra. According to an article in Daily News & Analysis, the state’s Food and Drug Administration (FDA) filed a complaint with the Mumbai police against DePuy. The primary problem for Indian authorities is that they don’t know how many people in their country received the hip replacements, though the article suggests 4,700 implants were sold there. Few Mumbai residents, however, appear to have received one, so the police are asking residents to step forward and report if they are among them.
One FDA official stated, “The Police are investigating. Once the implant recipients come forward, we will know how many are affected, and accordingly take action against the company.”
Indian Orthopedists React
As soon as the DePuy hip recall began in August 2010, orthopedists in Mumbai claim they immediately ceased using the ASR. One also said that until now, no one has reported hip replacement problems, and tests have not shown symptoms of metal poisoning. Although no one has undergone revision surgery of an ASR, some have received care for parts loosening or wearing out. As in the United States and elsewhere, DePuy has promised to reimburse recipients up through revising a failed implant.
RLG Advocates for Injured ASR Recipients
All over the world: Australia, Ireland, the United Kingdom, the United States, and now India, the DePuy recall is having repercussions. Whether this latest news will result in lawsuits against the manufacturer is something to watch out for, but hopefully no one has suffered the kinds of debilitating injuries that have caused others to take action. If you received an ASR and believe it injured you, it’s important to know that the amount of compensation from a hip replacement lawsuit might be greater than going through DePuy’s reimbursement program, as those in India appear to be considering. A lawsuit can get you damages for medical expenses, lost wages, money for pain and suffering as well as harm to your marriage, and possibly punitive damages. For a free consultation with the Rottenstein Law Group, all you need to do is click on this link, or complete the contact form to the right. Otherwise, feel free to download this free DePuy ASR brochure.
- US Drug Watchdog Urges All ASR DePuy Hip Implant Recipients to Get Identified and Lists the Most Common Symptoms of a Hip Implant Failure (earlsview.com)
- Recalled DePuy ASR Hip Implant Lawsuits Filed By The Law Offices Of John David Hart – TheStreet (earlsview.com)
- Financial toll soars for hip implant failures – KansasCity.com (earlsview.com)
- DePuy Hip Recall | Pinnacle Hip Recall News (earlsview.com)
- RLG Heeds Common Benefit Order in DePuy ASR MDL (earlsview.com)
- Rottenstein Law Group Heeds Common Benefit Order in DePuy ASR MDL – Yahoo! News (earlsview.com)
- J&J Third Quarter Earnings Report: Approximately 560 DePuy Pinnacle Lawsuits Filed (earlsview.com)
- San Francisco Personal Injury Attorney Analyzes Depuy Lawsuits And Preemption (earlsview.com)
- US Drug Watchdog Says It’s Urgent They Identify All Recalled DePuy ASR Hip Implant Recipients (earlsview.com)
- Watch out for the DePuy BS campaign – coming to a town near you…. (earlsview.com)